29 Biotech stocks on the move after news Posted by Jessica

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

29 Biotech stocks on the move after news

Posted by on Jan 09, 2013

The BioEnterprise Midwest Healthcare Venture Investment report revealed that healthcare technology companies in Ohio attracted $292 million in 2012, scoring a 65 percent growth from 2011, when $178 million was invested.

By sector, 2012 equity funding in the Midwest was to be paid to biopharmaceutical companies ($487 million), medical device companies ($309 million) and healthcare IT and service companies ($177 million).

In corporate news, Cell Therapeutics Inc (NASDAQ:CTIC) led biotech gainers on Tuesday after it launched clinical trial sites and started enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib.

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) skyrocketed after a report claimed the company is testing new drugs to defeat hypoxia in tumors.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) got a boost yesterday after President and CEO Jack Lief said the company is seeking partners to sell its weight-loss drug Belviq abroad once it clears regulatory hurdles.

Celgene Corporation (NASDAQ:CELG) jumped to new high on 2013 financial forecast and preliminary 2012 results.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) surged 5.60% a day after it announced completion of enrollment in Phase IIa hepatitis C trial.

Incyte Corporation (NASDAQ:INCY) advanced after its presentation at the JPMorgan Healthcare Conference revealed plans to focus on getting physicians to prescribe Jakafi earlier in the disease progression process and that it seeks more support about just how safe and effective the drug is.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) added 5% after providing its full-year 2013 strategic outlook and financial guidance.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) increased 4% after a report that the company is teaming up with the U.K. National Cancer Research Institute for a phase 3 trial, named SPIRIT, to assess the impact of switching chronic myeloid leukemia patients treated with a first-line tyrosine kinase inhibitor to Ponatinib.

Illumina, Inc. (NASDAQ:ILMN) gained $1.5 after declaring a series of product and technology innovations for its powerful sequencing ecosystem.

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) was up after David Meeker , M.D., President and Chief Executive Officer of Genzyme, a Sanofi Company, was elected to Savient’s Board of Directors, effective January 7, 2013.

Gilead Sciences, Inc. (NASDAQ:GILD) hit new 52-week high after signing antibody development deal with MacroGenics.

Some other positive hot stocks in the biotechnology industry were Biosante Pharmaceuticals Inc (NASDAQ:BPAX), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR), MannKind Corporation (NASDAQ:MNKD) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

On the flip side, Neostem Inc. (NYSEAMEX:NBS) was among the biggest losers following an announcement that Hackensack University Medical Center renewed its engagement of Progenitor Cell Therapy’s services for processing and storage of a variety of cell types used therapeutically by the hospital.

NuPathe Inc (NASDAQ ATH) turned red on Tuesday.

Dendreon Corporation (NASDAQ NDN) continued to decline after announcing preliminary fourth quarter 2012 revenues.

Sequenom, Inc. (NASDAQ:SQNM) was down after Illumina acquired rival.

Peregrine Pharmaceuticals (NASDAQ PHM) retreated after earningforecast issued consensus earnings forecast report on the company.

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) plunged after predicting net loss bewteen $115 Mln and $125 Mln for 2013.

VIVUS, Inc. (NASDAQ:VVUS) was down after unusual trading activity was linked to a possible insider trade.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) lost $5.9 after reporting lower-than-expected sales for its eye drug Eylea.

Complete Genomics, Inc. (NASDAQ:GNOM) decreased after rumors that Illumina (NASDAQ:ILMN) has withdrawn its bid to takeover GNOM.

Biogen Idec Inc. (NASDAQ:BIIB) edged down yesterday as it needs strong BG-12 launch to maintain momentum.

More on the flip side included Rexahn Pharmaceuticals, Inc. (NYSEAMEX:RNN), Hemispherx BioPharma, Inc (NYSEAMEX:HEB), Amgen, Inc. (NASDAQ:AMGN) and Celsion Corporation (NASDAQ:CLSN).

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 14

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 16

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 15

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 16

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 21

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 14

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Recent Options Trends for Boeing Stock

Updated Category News Views 263

Market Sentiment Surrounding Boeing's Options In recent times, a notable trend has emerged among significant investors regarding Boeing (NYSE: BA). This isn't just casual market gossip; it's evidence of serious financial maneuvers that could hold substantial implications for the stock. Insight into publicly available options data highlights a shift in sentiment that savvy...

Continue Reading
Analyzing the Surge in Ford Motor's Short Interest Figures

Updated Category News Views 241

Ford Motor's Increasing Short Interest Overview Recently, Ford Motor Company's short interest has drawn significant attention. The percentage of short interest has increased by 4.44%, indicating a total of 180.65 million shares sold short. This figure represents 5.17% of the total regular shares available for trading. The current trading volume implies that it would take...

Continue Reading
Nutex Health Inc. Faces Scrutiny Amid Claims of Misconduct

Updated Category News Views 221

Investigation into Nutex Health Inc. Recently, there has been a growing focus on Nutex Health Inc. as serious allegations of misconduct arise. Investors of the company are understandably concerned as investigations unfold about whether their leadership has engaged in fraudulent practices that could affect their investments. In light of these events, it is crucial for...

Continue Reading
Revolutionizing Logistics: ITF Group Teams Up with HaulerHub

Updated Category News Views 156

Transforming Logistics through Innovation ITF Group has forged an exciting partnership with HaulerHub to launch a platform that revolutionizes the connection between shippers and haulers. This innovative platform is designed to bring a thoroughly vetted and verified network of haulers to the forefront, addressing long-standing issues within the logistics industry....

Continue Reading
CRRC Innovates with Sustainable Transport Solutions Revolutionizing Cities

Updated Category News Views 176

CRRC Transforms Passenger Transport Solutions at InnoTrans 2024 During the highly regarded InnoTrans 2024 event, CRRC Corporation Limited (SHA: 601766) presented an impressive lineup of cutting-edge passenger transport solutions. Highlighting their commitment to sustainability and innovation, these solutions fit a range of speed categories and operational contexts under...

Continue Reading